NCT02748642View on ClinicalTrials.gov

A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Participants With Mild Atopic Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 7, 2016

Primary Completion Date

June 14, 2017

Study Completion Date

June 14, 2017

Conditions
Mild Atopic Asthma
Interventions
DRUG

BITS7201A

BITS72014A will be administered on Day 1 in Part A and on Days 1, 28, and 57 in Part B.

DRUG

Placebo

Placebo matched to BITS72014A will be administered on Day 1 in Part A and on Days 1, 28, and 57 in Part B.

Trial Locations (1)

37920

New Orleans Center for Clinical Research; Volunteer Research Group, Knoxville

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY